首页 / 院系成果 / 成果详情页

Emodin: Its role in prostate cancer-associated inflammation 期刊论文

编号：

94bd6190-39bc-40eb-8b9e-01ee81f905b0
作者：

Tu, Yanjie(屠燕捷)#^[1,2]Wu, Zhonghua(吴中华)^[1,3]Tan, Bo^[1,2,4]Yang, Aidong(杨爱东)*^[1,2]Fang, Zhaoqin(方肇勤)*^[1,3]
语种：

英文
期刊：

ONCOLOGY REPORTS ISSN：1021-335X 2019 年 42 卷 4 期 (1259 - 1271) ; OCT
收录：
关键词：

prostate cancer emodin inflammation immune therapy
摘要：

Prostate cancer is one of the most common malignancies diagnosed in males. Cancer-related inflammatory factors include tumor necrosis factor, inflammasomes, cytokines, chemokines, transcription factors, infiltrating or circulating immune cells, reactive oxygen species, and sex hormone receptors. These are mainly associated with the local immune response at the tumor site. Emodin, a chemical compound that can be isolated from the plant rhubarb among others, has been shown to exhibit anti-inflammatory and anticancer properties in prostate cancer. This review summarizes the effects of emodin on prostate cancer and analyzes whether it interferes with prostate cancer through anti-inflammatory pathways. New information regarding the development of emodin derivatives including their increased solubility and reduced side effects through chemical structure modifications is also reviewed.
推荐引用方式
GB/T 7714：

Tu Yanjie,Wu Zhonghua,Tan Bo, et al. Emodin: Its role in prostate cancer-associated inflammation [J].ONCOLOGY REPORTS,2019,42(4):1259-1271.
APA：

Tu Yanjie,Wu Zhonghua,Tan Bo,Yang Aidong,&Fang Zhaoqin.(2019).Emodin: Its role in prostate cancer-associated inflammation .ONCOLOGY REPORTS,42(4):1259-1271.
MLA：

Tu Yanjie, et al. "Emodin: Its role in prostate cancer-associated inflammation" .ONCOLOGY REPORTS 42,4(2019):1259-1271.
入库时间：

1/6/2020 6:09:54 PM
更新时间：

1/6/2020 6:09:54 PM
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：110  下载次数：0

分享到：

浏览次数：110

下载次数：0

打印次数：0